IMR Press / FBL / Volume 4 / Issue 4 / DOI: 10.2741/berndt

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Protein dephosphorylation and the intracellular control of the cell number
Show Less
1 Childrens Hospital Los Angeles, USC School of Medicine, Los Angeles, CA 90027, USA
Academic Editor:Marcelo Tolmasky
Front. Biosci. (Landmark Ed) 1999, 4(4), 22–42;
Published: 1 January 1999

Regulating the cell number is critically important for the development and maintenance of a multi-cellular organism. The cell number can be altered by inducing cell proliferation and/or programmed cell death (apoptosis). These two processes are linked by cell cycle-regulatory pathways, and protein phosphorylation and proteolytic degradation play key roles in both. Protein dephosphorylation has been a rather neglected aspect of cell cycle control. Recent advances in this field make it imperative to provide a view of the cell cycle from a phosphatase's vantage point. Although a number of protein phosphatases may be instrumental in cell cycle and apoptosis control, the emphasis here will be on the prototypical Ser/Thr-specific protein phosphatase PP1. Experiments will be considered in their historical context. The major goal of this review will be to re-evaluate the hypothesis that PP1 - and other protein phosphatases - may function as negative growth regulators. Currently available evidence suggests that PP1 activity is required for exit from mitosis, yet may also block cell cycle progression and facilitate apoptosis. Where appropriate, results highlighting the role of the other major phosphatase, PP2A, will also be discussed. This review will conclude with some unresolved issues including the question whether PP1 might be a suitable target for anti-cancer strategies.

Protein phosphatase 1
protein phosphatase 2A
cell cycle
cyclin-dependent kinase
tumor suppressor
CDK inhibitor
RB protein
Back to top